These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21761366)

  • 21. Mutations in exon 3 of the CTNNB1 gene (beta-catenin gene) in cutaneous adnexal tumors.
    Kazakov DV; Sima R; Vanecek T; Kutzner H; Palmedo G; Kacerovska D; Grossmann P; Michal M
    Am J Dermatopathol; 2009 May; 31(3):248-55. PubMed ID: 19384065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis.
    Preda V; Larkin SJ; Karavitaki N; Ansorge O; Grossman AB
    Endocr Pathol; 2015 Mar; 26(1):1-8. PubMed ID: 25355426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.
    Hölsken A; Sill M; Merkle J; Schweizer L; Buchfelder M; Flitsch J; Fahlbusch R; Metzler M; Kool M; Pfister SM; von Deimling A; Capper D; Jones DT; Buslei R
    Acta Neuropathol Commun; 2016 Feb; 4():20. PubMed ID: 26927026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic drivers in craniopharyngiomas: Analysis of the AACR project GENIE database.
    Lehrich MB; Tong CLC; Hsu PKF; Kuan CE
    Childs Nerv Syst; 2024 Jun; 40(6):1661-1669. PubMed ID: 38421446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.
    Brastianos PK; Taylor-Weiner A; Manley PE; Jones RT; Dias-Santagata D; Thorner AR; Lawrence MS; Rodriguez FJ; Bernardo LA; Schubert L; Sunkavalli A; Shillingford N; Calicchio ML; Lidov HG; Taha H; Martinez-Lage M; Santi M; Storm PB; Lee JY; Palmer JN; Adappa ND; Scott RM; Dunn IF; Laws ER; Stewart C; Ligon KL; Hoang MP; Van Hummelen P; Hahn WC; Louis DN; Resnick AC; Kieran MW; Getz G; Santagata S
    Nat Genet; 2014 Feb; 46(2):161-5. PubMed ID: 24413733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.
    Baş F; Uyguner ZO; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Şiklar Z; Öcal G; Darcan Ş; Gökşen D; Topaloğlu AK; Yüksel B; Özbek MN; Ercan O; Evliyaoğlu O; Çetinkaya S; Şen Y; Atabek E; Toksoy G; Aydin BK; Bundak R
    Endocrine; 2015 Jun; 49(2):479-91. PubMed ID: 25500790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
    Sekine S; Shibata T; Kokubu A; Morishita Y; Noguchi M; Nakanishi Y; Sakamoto M; Hirohashi S
    Am J Pathol; 2002 Dec; 161(6):1997-2001. PubMed ID: 12466115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans.
    Gaston-Massuet C; Andoniadou CL; Signore M; Jayakody SA; Charolidi N; Kyeyune R; Vernay B; Jacques TS; Taketo MM; Le Tissier P; Dattani MT; Martinez-Barbera JP
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11482-7. PubMed ID: 21636786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models.
    Martinez-Barbera JP
    J Endocrinol; 2015 Aug; 226(2):T161-72. PubMed ID: 25926515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas.
    Rickert CH; Paulus W
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):260-1. PubMed ID: 12531965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
    Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
    Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation.
    Hara T; Akutsu H; Takano S; Kino H; Ishikawa E; Tanaka S; Miyamoto H; Sakamoto N; Hattori K; Sakata-Yanagimoto M; Chiba S; Hiyama T; Masumoto T; Matsumura A
    J Neurosurg; 2019 Jul; 131(1):217-226. PubMed ID: 30074466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors.
    Garcia-Lavandeira M; Saez C; Diaz-Rodriguez E; Perez-Romero S; Senra A; Dieguez C; Japon MA; Alvarez CV
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E80-7. PubMed ID: 22031517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Craniopharyngioma in Pediatrics and Adults.
    Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
    Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere length and Wnt/β-catenin pathway in adamantinomatous craniopharyngiomas.
    Mota JIS; Silva-Júnior RMP; Martins CS; Bueno AC; Wildemberg LE; Antunes XLDS; Ozaki JGO; Coeli-Lacchini FB; Garcia-Peral C; Oliveira AER; Santos AC; Moreira AC; Machado HR; Dos Santos MV; Colli LM; Gadelha MR; Antonini SRR; de Castro M
    Eur J Endocrinol; 2022 Jun; 187(2):219-230. PubMed ID: 35584004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma.
    Martinez-Barbera JP; Andoniadou CL
    Stem Cells; 2016 Feb; 34(2):268-76. PubMed ID: 26763580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency.
    Vieira TC; Boldarine VT; Abucham J
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1097-103. PubMed ID: 18157385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.
    Andoniadou CL; Gaston-Massuet C; Reddy R; Schneider RP; Blasco MA; Le Tissier P; Jacques TS; Pevny LH; Dattani MT; Martinez-Barbera JP
    Acta Neuropathol; 2012 Aug; 124(2):259-71. PubMed ID: 22349813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
    Cao J; Lin JP; Yang LX; Chen K; Huang ZS
    Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.
    Hölsken A; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
    Acta Neuropathol; 2010 May; 119(5):631-9. PubMed ID: 20131060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.